These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3233579)

  • 21. An overview of contemporary management of breast carcinoma.
    Suhrland LG
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):783-96. PubMed ID: 3323974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Brown RJ; Davidson NE
    Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing the future: combination with targeted therapies, adjuvant setting and beyond.
    Goss PE
    Anticancer Drugs; 2008 Mar; 19 Suppl 2():S3-5. PubMed ID: 18337641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?
    Bedard PL; Freedman OC; Howell A; Clemons M
    Breast Cancer Res Treat; 2008 Apr; 108(3):307-17. PubMed ID: 18351454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.
    Cunnick G; Mokbel K
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):197-8. PubMed ID: 16468468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of long-term survivors after treatment of thoracic metastases from breast cancer by hormone therapy and nonhormonal antineoplastic chemotherapy combined from the onset].
    Mannes P; Derriks R; Moens R
    Rev Tuberc Pneumol (Paris); 1972; 36(3):460-4. PubMed ID: 5080970
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy studies of the Austrian Breast Cancer Group (ABC)].
    Jakesz R; Hausmaninger H; Samonigg H; Kubista E; Haider K; Mlineritsch B; Schmid M; Tausch C; Reiner G; Renner K; Stierer M; Jatzko G; Hofbauer F; Fridrik M; Schennach W; Sevelda P; Dadak C; Haid A; Scholz R; Lenzhofer P; Steindorfer P; Berger A; Mischinger HJ
    Zentralbl Chir; 1998; 123 Suppl 5():28-32. PubMed ID: 10063568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possibilities and limitations of endocrine therapy of metastasizing breast cancer].
    Nowakowski H
    Verh Dtsch Ges Inn Med; 1967; 73():505-18. PubMed ID: 5591802
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
    Brunner KW
    Schweiz Med Wochenschr; 1969 Sep; 99(36):1298-303. PubMed ID: 5351150
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relation between estrogen and progesterone receptors and response to hormone therapy].
    Leclercq G; Paridaens R; Heuson JC
    Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormones and cancer].
    Med Klin; 1967 May; 62(20):789-91. PubMed ID: 4297507
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hormone therapy of metastasizing breast carcinoma].
    Hagen MF; Thürlimann B
    Ther Umsch; 1996 Nov; 53(11):820-8. PubMed ID: 8984687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Dec; (8):1785-810. PubMed ID: 12603970
    [No Abstract]   [Full Text] [Related]  

  • 35. Fertility preservation in (breast) cancer patients: is it safe?
    Wildiers H; Neven P; Amant F; D'hooghe T; Paridaens R
    J Clin Oncol; 2006 Nov; 24(33):5335-6; author reply 5337-8. PubMed ID: 17114672
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bone metastases of breast cancer. Diagnosis and hormone treatment].
    Schermuly W
    Strahlentherapie Sonderb; 1964; 56():1-147. PubMed ID: 5827725
    [No Abstract]   [Full Text] [Related]  

  • 37. [Breast cancer--topics from basic research].
    Matsumoto K; Kuroda H; Takeyama M
    Gan To Kagaku Ryoho; 1984 May; 11(5):974-80. PubMed ID: 6721515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.
    Altundag K; Altundag O
    J Clin Oncol; 2003 Dec; 21(24):4656; author reply 4657. PubMed ID: 14673060
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
    Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
    Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.